Physician profile
Van Q Tran
NPI 1194753665
$7,009.22
in general payments reported to CMS, 2019-2025
59 companies · $552 in 2025
The $552 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,516 · 2020: $424 · 2021: $1,431 · 2022: $1,244 · 2023: $858 · 2024: $983 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,393.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $980.12 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $787.93 | 2021-2025 | |
| Abbvie INC. | $617.76 | 2021-2025 | Vraylar, Qulipta |
| Kowa Pharmaceuticals America, INC. | $506.84 | 2019-2023 | Seglentis, Livalo |
| Lilly USA, LLC | $390.47 | 2019-2025 | Jardiance, Mounjaro |
| Pfizer INC. | $311.23 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $237.48 | 2020-2025 | Xifaxan, Trulance |
| Astrazeneca Pharmaceuticals Lp | $198.45 | 2019-2024 | Farxiga, Airsupra |
| Amarin Pharma, INC. | $196.36 | 2021-2022 | |
| Corium, LLC | $187.33 | 2021-2024 | Azstarys |
| Abbott Laboratories | $169.10 | 2021 | |
| Dexcom, INC. | $145.08 | 2022-2024 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $133.18 | 2019-2022 | |
| Allergan, INC. | $127.43 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $116.64 | 2021-2023 |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $104.62 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $99.30 | 2023-2024 | Qelbree, Xyosted, Tlando |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.91 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $94.52 | 2019-2020 | |
| Inspire Medical Systems, INC. | $90.64 | 2023-2025 | Inspire |
| Corcept Therapeutics | $87.94 | 2021-2024 | Korlym |
| Amgen INC. | $87.71 | 2019-2024 | Otezla, Repatha, Prolia |
| Gilead Sciences, INC. | $78.01 | 2019-2022 | |
| Antares Pharma, INC. | $77.55 | 2024-2025 | Xyosted |
| Merck Sharp & Dohme LLC | $67.40 | 2019-2020 | |
| Tolmar, INC. | $66.70 | 2023-2024 | |
| Arbor Pharmaceuticals, INC. | $60.74 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $58.82 | 2021 | |
| Vertiflex, INC. | $58.63 | 2019 | |
| Ironwood Pharmaceuticals, INC | $57.42 | 2021-2024 | Linzess |
| Alcon Vision LLC | $51.93 | 2024 | Clareon |
| Viiv Healthcare Company | $49.70 | 2024 | Apretude |
| Teva Pharmaceuticals USA, INC. | $49.22 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $44.15 | 2021-2023 | Rexulti |
| Mannkind Corporation | $41.98 | 2019 | |
| Halozyme INC | $40.74 | 2023 | |
| Astellas Pharma US INC | $37.60 | 2023-2024 | Veozah |
| Esperion Therapeutics, INC. | $37.02 | 2024 | Nexletol |
| Glaxosmithkline, LLC. | $34.53 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Axsome Therapeutics, INC. | $33.74 | 2023-2024 | Auvelity |
| Eisai INC. | $27.06 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $24.30 | 2024 | Voquezna |
| Edwards Lifesciences Corporation | $23.89 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Tris Pharma INC | $22.90 | 2023 | Dyanavel Xr |
| Medicure Pharma INC. | $21.68 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $21.62 | 2021 | |
| Noven Therapeutics, LLC | $20.94 | 2024 | Xelstrym |
| Intra-Sana Laboratories | $20.07 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Sanofi Pasteur INC. | $19.84 | 2019 | |
| Currax Pharmaceuticals LLC | $16.99 | 2025 | Contrave |
| Horizon Therapeutics Plc | $15.96 | 2019 | |
| Sunovion Pharmaceuticals INC. | $15.09 | 2021 | |
| Genentech USA, INC. | $14.83 | 2021 | |
| Exact Sciences Corporation | $14.49 | 2024 | Cologuard Collection Kit |
| Almatica Pharma LLC | $13.53 | 2025 | Loreev Xr |
| Itamar Medical INC | $4.11 | 2024 | Watchpatone |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Van Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.